Results 121 to 130 of about 2,631 (193)
Valoración del riesgo de náuseas y vómitos posoperatorios
Dilia Cobas Varona
doaj +4 more sources
[Efficacy of chewing gum in post-cesarean ileus: A randomized clinical trial]. [PDF]
Cortes-Cernas VI +9 more
europepmc +1 more source
Managing massive tumor burden in synchronous endometrioid carcinomas. The graphical abstract summarizes the clinical pathway from presentation with massive ascites, pleural effusion, and critical metabolic abnormalities to multidisciplinary stabilization, surgical management, integrated morphologic–molecular classification, and shared decision‐making ...
Anna Homeniuk +2 more
wiley +1 more source
[Health workers exposed to pesticides: a cross-sectional study involving agents for the control of endemic diseases in the State of Rio de Janeiro, Brazil]. [PDF]
Vidal PJDSR +7 more
europepmc +1 more source
As use cases for long‐acting therapeutics expand across clinical indications, there is a critical need to ensure the inclusion of women who are pregnant or breastfeeding, infants and children—populations with a historical gap in the availability of interventions already approved for use in adults.
Moherndran Archary +59 more
wiley +1 more source
[Annular Pancreas in Adults. A Case Report]. [PDF]
Marulanda Fernández H +2 more
europepmc +1 more source
5‐hydroxytryptamine type 3 (5‐HT3) receptor antagonists are used to treat nausea and vomiting and in the prevention of chemotherapy‐induced, radiation‐induced, and postoperative nausea and vomiting. Most of the 5‐HT3 receptor antagonists (i.e., ondansetron, tropisetron, dolasetron, palonosetron, and ramosetron) are metabolized by CYP2D6, but the extent
Claire Moore +16 more
wiley +1 more source
Translation, Cross-Cultural Adaptation and Content Validity Assessment of the Spanish Diabetes Management Knowledge Assessment Tool-14 for Nursing Home Nurses. [PDF]
Domínguez-Navarro A +1 more
europepmc +1 more source
Repurposing Drugs for Malaria through a Human Dose Prediction: A Case Study with Berzosertib
Repurposing drugs whose clinical safety has been established offers a valuable approach to reduce the cost and time associated with the development of new drugs for malaria. Here, we investigate the potential to repurpose the anticancer kinase inhibitor berzosertib for the treatment of malaria, by assessing whether a predicted efficacious human dose ...
Devasha Redhi +5 more
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source

